Best practices to fight antimicrobial resistance
The International Coalition of Medicines Regulatory Authorities (ICMRA) highlights successful regulatory and non-regulatory interventions used in different countries to address the growing public health problem of antimicrobial resistance (AMR) in a new report published today.
AMR threatens our ability to effectively treat infections because of an ever-increasing range of bacteria and other microorganisms that have adapted to become resistant to available treatments.
Tackling AMR is one of ICMRA’s strategic priorities. ICMRA recognises that AMR is a complex, multifaceted problem and calls for better coordination across all sectors, including public health, animal health and the environment, through a ‘One Health’ approach. A concerted and collaborative effort is essential to address this threat to global health, economies and security effectively.
The report presents case studies on best practices from different countries that were developed in line with the ‘One Health’ approach and address AMR and antimicrobial use in humans, animals and the environment.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.